Margo Minissian, PhD, ACNP, NEA-BC, FAHA, FNLA

Margo B. Minissian, PhD, ACNP, NEA-BC, FAHA, FNLA is the Executive Director, Brawerman Institute and the Simms/ Mann Family Foundation Endowed Chair of Education, Innovation and Research. She is a Faculty Research Scientist, Assistant Professor of Cardiology at the Smidt Heart Institute at Cedars-Sinai Medical Center and at UCLA School of Nursing. She holds National Board Certifications as a Nurse Executive- Advanced and Acute Care Nurse Practitioner from the American Nurses Credentialing Center. She is also Nationally board certified as a Clinical Lipid Specialist from the Accreditation Council for Clinical Lipidology.

Dr. Minissian is the Director of the Postpartum Heart Health Program which has been designed to help identify, risk stratify and treat women who experience adverse pregnancy outcomes. She is funded by the National Institutes of Health (NIH) for the past 11 years. Dr. Minissian completed her biological research PhD at the University of California, Los Angeles (UCLA) School of Nursing, was a UCLA Dean's Scholar Fellow and a UCLA Regents Scholar. She is published in 60 peer reviewed journals including the Journal of Women's Health, Nurse Leader, and The Journal of the American College of Cardiology and Circulation. Dr. Minissian has a continuing passion for education and has contributed towards the design of national educational programs as well as being a speaker at many professional organizations nation-wide discussing the epidemic of women and heart disease, adverse pregnancy outcomes, and dyslipidemia complicated by statin myalgias. In addition, Dr. Minissian was co-author of the 2017 Focused Update of the 2016 American College of Cardiology (ACC) Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk and the ACC/ AHA Secondary Prevention Guidelines in which she chaired the smoking cessation section.